Guardant Health Stock Investor Sentiment
| GH Stock | USD 16.07 0.60 3.60% |
Under 78 percent of Guardant Health's traders are selling. The analysis of overall sentiment of trading Guardant Health stock suggests that a large number of investors are terrified at this time. Guardant Health's investor sentiment overview provides quick insight into current market opportunities from investing in Guardant Health. The current market sentiment, together with Guardant Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Guardant Health stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
22
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Guardant Health's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Guardant Health.
News SentimentBearish | Hype SentimentBearish | Insider SentimentDisposing |
Guardant Health stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Guardant daily returns and investor perception about the current price of Guardant Health as well as its diversification or hedging effects on your existing portfolios.
Guardant Historical Sentiment
Although Guardant Health's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Guardant, such as negative comments on social media and news outlets, may cause fear in the market and push Guardant Health's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Guardant.
Guardant |
Guardant Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Guardant Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Guardant Health Historical Investor Sentiment
Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Guardant Health news discussions. The higher the estimate score, the more favorable the investor's outlook on Guardant Health.
Far too much social signal, news, headlines, and media speculation about Guardant Health that are available to investors today. That information is available publicly through Guardant media outlets and privately through word of mouth or via Guardant internal channels. However, regardless of the origin, that massive amount of Guardant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Guardant Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Guardant Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Guardant Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Guardant Health alpha.
Guardant Health Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Guardant Health Inc Reports 25 percent Revenue Growth in Full Year 2023 | 02/22/2024 |
2 | Guardant Health, Inc. Shares Sold by Trexquant Investment LP | 02/28/2024 |
3 | Guardant Health, Inc. Stock Holdings Boosted by Seven Eight Capital LP | 03/06/2024 |
4 | California State Teachers Retirement System Has 3.66 Million Stock Holdings in Guardant Health, Inc. - Defense World | 03/11/2024 |
5 | Disposition of 1233 shares by Michael Bell of Guardant Health subject to Rule 16b-3 | 03/15/2024 |
6 | EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices | 03/18/2024 |
7 | GUARDANT HEALTH INC. Revenue Breakdown SWB5GH TradingView - TradingView | 03/21/2024 |
8 | Acquisition by Merrill Amelia of 158 shares of Guardant Health subject to Rule 16b-3 | 03/25/2024 |
9 | The next Nvidia 3 stocks poised for massive growth in 2024 | 04/03/2024 |
10 | Disposition of tradable shares by Joyce Meghan V. of Guardant Health subject to Rule 16b-3 | 04/04/2024 |
11 | Guardant Health Stock Price Up 4.9 percent - MarketBeat | 04/08/2024 |
12 | Disposition of tradable shares by Potter Myrtle S of Guardant Health subject to Rule 16b-3 | 04/15/2024 |
13 | Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024 | 04/18/2024 |
Check out Guardant Health Hype Analysis, Guardant Health Correlation and Guardant Health Performance. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.